Target intelligence / Profile preview

Secretome effects

Molecular classification
Other
01

Overview

The **secretome** is the total collection of bioactive factors secreted by cells into the extracellular space. These include a wide diversity of molecules such as proteins (growth factors, cytokines, chemokines), lipids, nucleic acids, metabolites, and extracellular vesicles (exosomes and microvesicles). The secretome is a key mediator of intercellular communication, playing central roles in regulating cell proliferation, apoptosis, immune responses, tissue regeneration, and homeostasis[1][3][4][5][7]. In regenerative medicine, the "stem cell secretome" refers to factors secreted by stem cells (especially mesenchymal stem cells), which are widely recognized as mediators of the therapeutic effects of stem cell-based interventions[1][4][5][7]. The use of secretome-based (cell-free) therapies is emerging as a promising alternative to direct cell therapies due to lower immunogenicity, easier storage and handling, and fewer safety concerns compared to transplanting live cells[1][3][7]. However, "secretome effects" is not the name of a specific molecular target; it describes the biological impact of this collective group of secreted molecules, and there is currently no standardized single entity or drug target formally called "Secretome effects"[5][7]. Key caveat: There is no canonical molecular target called "Secretome effects"; this entry is a category of cell-derived factors, not a discrete molecule, receptor, or druggable target. If seeking a therapeutically actionable molecule, you must specify one of the well-defined compounds or receptors within the secretome (e.g., "VEGF", "TGF-β", "exosome") rather than the general effect or collective products.

Other names
cell secretomestem cell secretomestromal cell secretomecellular secretome
02

Biological functions

Signal transductionCell communicationTissue regenerationImmune modulationHomeostasisCell proliferationApoptosisAngiogenesisInflammationAnti-fibrotic effectsOther
03

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseAutoimmune diseaseTissue injuryOther
04

Safety considerations

Heterogeneity of compositionBatch-to-batch variabilityLack of standardizationUnknown long-term effects

Beyond the preview

Go deeper on Secretome effects.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Secretome effects.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call